Author

Hua-Qiang Zhu

Observed name: H. Zhu

Institution: Genfleet Therapeutics (Shanghai) Inc. (China)

Observed institutions: Shandong Tumor Hospital, Shandong First Medical University, Genfleet Therapeutics (Shanghai) Inc. (China)

ORCID: 0009-0002-3934-4022

Observed ORCID: 0009-0002-3934-4022

OpenAlex ID: A5084626993

GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study

2025 · Lin-Quan Tang, Sai-Lan Liu, et al. · Clinical Cancer Research · 7

Data from GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study

2025 · Lin-Quan Tang, Sai-Lan Liu, et al.

Outcomes of First-Line Anti-PD-L1 Blockades Combined with Brain Radiotherapy (BRT) for Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) with Brain Metastases (BM)

2022 · Y. Tian, J. Ma, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 3

Citation count: 7

H-index: 1

I10-index: